Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-21-000169
Filing Date
2021-02-12
Accepted
2021-02-12 16:42:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ss192003_sc13g.htm SC 13G 45239
  Complete submission text file 0000947871-21-000169.txt   47103
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Subject) CIK: 0000882361 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-49893 | Film No.: 21628614
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED CAPITAL LLC (Filed by) CIK: 0001157524 (see all company filings)

EIN.: 134133323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G